Treatment of cutaneous leishmaniasis with nitric-oxide donor.
López-Jaramillo
P
P
Ruano
C
C
Rivera
J
J
Terán
E
E
Salazar-Irigoyen
R
R
Esplugues
J V
JV
Moncada
S
S
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000818:Animals; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007892:Leishmania braziliensis / Q000187:drug effects*; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D009569:Nitric Oxide / Q000502:physiology; D010396:Penicillamine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016896:Treatment Outcome
C110881:S-nitro-N-acetylpenicillamine; D009569:Nitric Oxide; D010396:Penicillamine